Manufacturer record
Yeluri Formulations Pvt Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Yeluri Formulations Pvt Ltd (Telangana) were declared Not of Standard Quality between February 2021 and April 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
5 records linked to Yeluri Formulations Pvt Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Gentamicin Injection I.P- 2ml | YGN4102Mfg 2024-07 · Exp 2026-06 | Sample does not conform to the requirement for pH.pH | King Institute ChennaiState lab | Apr 2025 |
| Shercef-TZ (Ceftriaxone and Tazobactam for Injection 1.125 gm) | YSZ3103Mfg 2023-07 · Exp 2025-06 | Completeness of solution, Clarity of Solution and Particulate MatterParticulate matter | CDL KolkataCDSCO lab | Dec 2023 |
| Cefepime and Tazobactam for Injection (Pimebest-TZ) | YBZ3101Mfg 2023-07 · Exp 2025-06 | Completeness of solution, Clarity of Solution and Particulate MatterParticulate matter | CDL KolkataCDSCO lab | Dec 2023 |
| Ceftriaxone For Injection USP (SHANU- CEFT 2 GM) | YSF3103Mfg 2023-08 · Exp 2026-07 | Constituted Solution & Particulate MatterParticulate matter | CDL KolkataCDSCO lab | Nov 2023 |
| Amoxycillin Capsules IP 500 mg | YAT91054Mfg 2019-11 · Exp 2021-10 | AssayAssay | CDTL MumbaiCDSCO lab | Feb 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.